ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 165 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.44 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $165,000 | -52.4% | 177,130 | +4.3% | 0.00% | -100.0% |
| Q4 2019 | $347,000 | -20.0% | 169,891 | +12.3% | 0.00% | 0.0% |
| Q3 2019 | $434,000 | -57.2% | 151,299 | +14.4% | 0.00% | -50.0% |
| Q2 2019 | $1,014,000 | -39.4% | 132,206 | +5.1% | 0.00% | -33.3% |
| Q1 2019 | $1,672,000 | -14.2% | 125,840 | +0.6% | 0.00% | -25.0% |
| Q4 2018 | $1,949,000 | -4.0% | 125,093 | +21.0% | 0.00% | 0.0% |
| Q3 2018 | $2,031,000 | -37.2% | 103,368 | -8.3% | 0.00% | -42.9% |
| Q2 2018 | $3,234,000 | +24.0% | 112,667 | +2.2% | 0.01% | +40.0% |
| Q1 2018 | $2,608,000 | +12.6% | 110,279 | +2.1% | 0.01% | 0.0% |
| Q4 2017 | $2,317,000 | +5.0% | 108,011 | +15.8% | 0.01% | 0.0% |
| Q3 2017 | $2,206,000 | +22.4% | 93,293 | +1.9% | 0.01% | +25.0% |
| Q2 2017 | $1,803,000 | -7.1% | 91,518 | -0.9% | 0.00% | -20.0% |
| Q1 2017 | $1,940,000 | +55.7% | 92,384 | +39.4% | 0.01% | +66.7% |
| Q4 2016 | $1,246,000 | -11.0% | 66,294 | -1.1% | 0.00% | -25.0% |
| Q3 2016 | $1,400,000 | -16.8% | 67,055 | +1.7% | 0.00% | -20.0% |
| Q2 2016 | $1,682,000 | +9.2% | 65,930 | +13.3% | 0.01% | 0.0% |
| Q1 2016 | $1,540,000 | -35.3% | 58,205 | +4.5% | 0.01% | -37.5% |
| Q4 2015 | $2,382,000 | +71.0% | 55,690 | +6.0% | 0.01% | +60.0% |
| Q3 2015 | $1,393,000 | -20.8% | 52,540 | -0.4% | 0.01% | -16.7% |
| Q2 2015 | $1,758,000 | +3.5% | 52,740 | +3.3% | 0.01% | +20.0% |
| Q1 2015 | $1,699,000 | -10.7% | 51,040 | +9.6% | 0.01% | -16.7% |
| Q4 2014 | $1,903,000 | +16.2% | 46,565 | -3.7% | 0.01% | +20.0% |
| Q3 2014 | $1,638,000 | -2.3% | 48,345 | -2.8% | 0.01% | 0.0% |
| Q2 2014 | $1,676,000 | -11.5% | 49,725 | -0.4% | 0.01% | -16.7% |
| Q1 2014 | $1,893,000 | +29.2% | 49,932 | -0.5% | 0.01% | +50.0% |
| Q4 2013 | $1,465,000 | -21.5% | 50,172 | -7.9% | 0.00% | -33.3% |
| Q3 2013 | $1,867,000 | +8.9% | 54,462 | +4.8% | 0.01% | 0.0% |
| Q2 2013 | $1,714,000 | – | 51,948 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 815,838 | $27,192,000 | 3.30% |
| ARMISTICE CAPITAL, LLC | 186,000 | $6,199,000 | 2.23% |
| 1492 Capital Management LLC | 95,639 | $3,188,000 | 2.02% |
| Partner Investment Management, L.P. | 19,498 | $650,000 | 0.91% |
| Tekla Capital Management LLC | 680,862 | $22,693,000 | 0.82% |
| PFM Health Sciences, LP | 817,396 | $27,244,000 | 0.69% |
| HighPoint Advisor Group LLC | 11,829 | $394,000 | 0.61% |
| ARBOR CAPITAL MANAGEMENT LLC | 89,183 | $2,972,000 | 0.56% |
| Pergamon Offshore Advisors, L.P. | 15,950 | $532,000 | 0.56% |
| Penn Capital Management Company, LLC | 390,212 | $13,006,000 | 0.54% |